CORC

在结果中检索

CORC

浏览/检索结果: 共343条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Simulation and experimental investigation on linear expansion micro-stress assembly process of adhesive bonded mirror 会议论文
Kunming, China, 2021-12-07
作者:  Zheng, Xiang-Ke;  Kang, Shi-Fa;  Wang, Peng;  Li, Hua;  Shu, Lin-Sen
收藏  |  浏览/下载：27/0  |  提交时间：2022/04/27
Study on assembly technology of primary and secondary mirror system based on truss structure 会议论文
Chengdu, China, 2021-06-14
作者:  Peng, Wang;  Xing, Song;  Xiao-Hua, Hou;  Zhong, Shen
收藏  |  浏览/下载：14/0  |  提交时间：2022/03/10
Research on technology of measuring and correcting the optical axis deviation of high-order aspheric lens 会议论文
Shanghai, China, 2020-06-29
作者:  Xihong, Fu;  Shifa, Kang;  Yu, Lei;  Hua, Li;  Peng, Wang
收藏  |  浏览/下载：46/0  |  提交时间：2020/12/21
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：44/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：34/0  |  提交时间：2019/12/05
Discriminative Regularization with Conditional Generative Adversarial Nets for Semi-Supervised Learning 会议论文
作者:  Xie, Qianqian;  Peng, Min;  Huang, Jimin;  Wang, Bin;  Wang, Hua
收藏  |  浏览/下载：7/0  |  提交时间：2019/12/05
Dilated Convolutional Networks Incorporating Soft Entity Type Constraints for Distant Supervised Relation Extraction 会议论文
作者:  Peng, Min;  Hu, Weilong;  Tian, Gang;  Wang, Bin;  Wang, Hua
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05
A Computer Immune Optimization Algorithm Based on Group Evolutionary Strategy 会议论文
作者:  Yang, Fan;  Zhang, Hua-li;  Peng, Lu
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：36/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace